Age at menopause and mortality in Japan: The Jichi medical school cohort study

Journal of Epidemiology

Volumn 16, Issue 4, 2006, Pages 161-166

  Amagai, Yoko ^a   Ishikawa, Shizukiyo ^a   Gotoh, Tadao ^b   Kayaba, Kazunori ^c   Nakamura, Yosikazu ^a   Kajii, Eiji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Wara National Health Insurance Hospital   (Japan)

^c SAITAMA PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Cohort studies; Japan; Menopause; Mortality; Premature

Indexed keywords

ADULT; AGE; AGED; ARTICLE; FEMALE; FOLLOW UP; HUMAN; JAPAN; MENOPAUSE; MIDDLE AGED; MORTALITY; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; RURAL POPULATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; MENOPAUSE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; RURAL POPULATION;

EID: 33746344056     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.16.161     Document Type: Article

References (40)

1. de Kleijn MJ, van der Schouw YT, Verbeek AL, Peeters PH, Banga JD, van der Graaf Y. Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol 2002; 155: 339-45.
2. van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet 1996; 347: 714-8.
3. Jacobsen BK, Nilssen S, Heuch I, Kvale G. Does age at natural menopause affect mortality from ischemic heart disease? J Clin Epidemiol 1997; 50: 475-9.
4. Hu FB, Grodstein F, Hennekens CH, Colditz GA, Johnson M, Manson JE, et al. Age at natural menopause and risk of cardiovascular disease. Arch Intern Med 1999; 159: 1061-6.
5. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20: 47-63.
6. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801-11.
7. Krasinski K, Spyridopoullos I, Asahara T, van der Zee R, Isner JM, Losordo DW. Estradiol accelerates functional endothelial recovery after arterial injury. Circulation 1997; 95: 1768-72.
8. Spyridopoulos I, Sullivan AB, Kearney M, Isner JM, Losordo DW. Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor. Circulation 1997; 95: 1505-14.
9. Pare G, Krust A, Karas RH, Dupont S, Aronovitz M, Chambon P, et al. Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res 2002; 90: 1087-92.
10. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/ progestin Replacement Study (HERS) Research Group. JAMA 1998; 280: 605-13.
11. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002; 288: 49-57.
12. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.
13. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350: 1047-59.
14. Monninkhof EM, van der Schouw YT, Peeters PH. Early age at menopause and breast cancer: are leaner women more protected? A prospective analysis of the Dutch DOM cohort. Breast Cancer Res Treat 1999; 55: 285-91.
15. de Graaff J, Stolte LA. Age at menarche and menopause of uterine cancer patients. Eur J Obstet Gynecol Reprod Biol 1978; 8: 187-93.
16. Franceschi S, La Vecchia C, Booth M, Tzonou A, Negri E, Parazzini F, et al. Pooled analysis of 3 European case-control studies of ovarian cancer: II. Age at menarche and at menopause. Int J Cancer 1991; 49: 57-60.
17. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal hormone replacement therapy: scientific review. JAMA 2002; 288: 872-81.
18. Ossewaarde ME, Bots ML, Verbeek AL, Peeters PH, van der Graaf Y, Grobbee DE, et al. Age at menopause, cause-specific mortality and total life expectancy. Epidemiology 2005; 16: 556-62.
19. Jacobsen BK, Heuch I, Kvale G. Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol 2003; 157: 923-9.
20. Cooper GS, Sandler DP. Age at natural menopause and mortality. Ann Epidemiol 1998; 8: 229-35.
21. Jacobsen BK, Knutsen SF, Fraser GE. Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. J Clin Epidemiol 1999; 52: 303-7.
22. Ishikawa S, Gotoh T, Nago N, Kayaba K. The Jichi Medical School (JMS) Cohort Study: design, baseline data and standardized mortality ratios. J Epidemiol 2002; 12: 408-17.
23. Conway GS. Premature ovarian failure. Br Med Bull 2000; 56: 643-9.
24. Anasti JN. Premature ovarian failure: an update. Fertill Steril 1998; 70: 1-15.
25. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986; 67: 604-6.
26. Zinn AR. The X chromosome and the ovary. J Soc Gynecol Investig 2001; 8(1 Suppl Proceedings): S34-6.
27. Conway GS. Premature ovarian failure. Curr Opin Obstet Gynecol 1997; 9: 202-6.
28. Tibiletti MG, Testa G, Vegetti W, Alagna F, Taborelli M, Dalpra L, et al. The idiopathic forms of premature menopause and early menopause show the same genetic pattern. Hum Reprod 1999; 14: 2731-4.
29. Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HS. Characterization of idiopathic premature ovarian failure. Fertil Steril 1996; 65: 337-41.
30. Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997; 18: 107-34.
31. Waggoner DD, Buist NR, Donnell GN. Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inherit Metab Dis 1990; 13: 802-18.
32. Wood C. Mumps and the menopause. Br J Sex Med 1975; 2: 19.
33. Fox H. The pathology of premature ovarian failure. J. Pathol 1992; 167: 357-63.
34. Morrison JC, Givens JR, Wiser WL, Fish SA. Mumps oophoritis: a cause of premature menopause. Fertil Steril 1975; 26: 655-9
35. Koyama H, Wada T, Nishizawa Y, Iwanaga T, Aoki Y. Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer 1977; 39: 1403-9.
36. Howell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am 1998; 27: 927-43.
37. Witteman JC, Grobbee DE, Kok FJ, Hofman A, Valkenburg HA. Increased risk of atherosclerosis in women after the menopause. BMJ 1989; 298: 642-4.
38. Joakimsen O, Bonaa KH, Stensland-Bugge E, Jacobsen BK. Population-based study of age at menopause and ultrasound assessed carotid atherosclerosis: The Tromso Study. J Clin Epidemiol 2000; 53: 525-30.
39. den Tonkelaar I. Validity and reproducibility of self-reported age at menopause in women participating in the DOM-project. Maturitas 1997; 27: 117-23.
40. Colditz GA, Stampfer MJ, Willett WC, Stason WB, Rosner B. Hennekens CH, et al. Reproducibility and validity of self-reported reported menopausal status in a prospective cohort study. Am J Epidemiol 1987; 126: 319-25.